Level Chart

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 16.30%, compared to 13.30% last quarter and 14.40% last year. This is higher than the long term average of 8.98%.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 16.30%
Latest Period Mar 2024
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Long Term Average 8.98%
Average Growth Rate 315.5%
Value from Last Quarter 13.30%
Change from Last Quarter 22.56%
Value from 1 Year Ago 14.40%
Change from 1 Year Ago 13.19%
Frequency Quarterly
Unit Percent
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
March 31, 2024 16.30%
December 31, 2023 13.30%
September 30, 2023 10.60%
June 30, 2023 13.40%
March 31, 2023 14.40%
December 31, 2022 9.40%
September 30, 2022 12.60%
June 30, 2022 7.80%
March 31, 2022 10.80%
Date Value
December 31, 2021 27.00%
September 30, 2021 18.50%
June 30, 2021 43.90%
March 31, 2021 5.40%
December 31, 2020 -13.50%
September 30, 2020 -10.40%
June 30, 2020 -25.30%
March 31, 2020 -2.50%
December 31, 2019 10.00%

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 16.30%, compared to 13.30% last quarter and 14.40% last year. This is higher than the long term average of 8.98%.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 16.30%
Latest Period Mar 2024
Last Updated Apr 30 2024, 08:41 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Long Term Average 8.98%
Average Growth Rate 315.5%
Value from Last Quarter 13.30%
Change from Last Quarter 22.56%
Value from 1 Year Ago 14.40%
Change from 1 Year Ago 13.19%
Frequency Quarterly
Unit Percent
Adjustment N/A

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp 1.14%